Concord Medical Services Holdings Limited (NYSE:CCM) Shares Shorted: Short Interest Down 37.5% in October

Concord Medical Services Holdings Limited (NYSE:CCM) was the recipient of a large decline in short interest in the month of October. As of October 15th, there was short interest totaling 6,821 shares, a decline of 37.5% from the September 30th total of 10,916 shares. Based on an average trading volume of 11,855 shares, the short-interest ratio is presently 0.6 days. Currently, 0.3% of the shares of the company are short sold.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CCM shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Concord Medical Services in a report on Friday, August 21st. Wall Street Zen raised Concord Medical Services to a “hold” rating in a report on Saturday, August 15th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Concord Medical Services Trading Up 6.5%

Shares of Concord Medical Services stock traded up $0.23 on Tuesday, hitting $3.82. 33,404 shares of the company traded hands, compared to its average volume of 35,030. The business has a 50-day simple moving average of $3.86 and a 200 day simple moving average of $4.20. Concord Medical Services has a 52 week low of $2.79 and a 52 week high of $6.80.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited was a China-based healthcare services company focused primarily on cancer treatment and diagnostic imaging. The company operated and managed medical facilities that provided radiotherapy, diagnostic imaging, and related oncology services, often through partnerships with hospitals and other healthcare institutions.

Its business also included the provision of medical equipment, technology, and management services to healthcare providers. Concord Medical’s facilities and partnerships were concentrated in China, with a focus on expanding access to specialized cancer diagnosis and treatment in major cities and regional medical centers.

Founded in 2006 and headquartered in Beijing, Concord Medical was historically led by founder and chief executive officer Dr.